SLC35A2 and cancer: Many studies have further shown abundant expression of UGT genes in a variety of human cancers and their associations with tumor progression and recurrence as well as patient survival, highlighting the impact of the intratumoral metabolism of anticancer drugs and other pro/anti-cancer signaling molecules through the UGT conjugation pathway [22,29,30,39,40,41,42,43,44,45,46].